Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3678 | 1855 | 34.2 | 76% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1032 | 9719 | METABOLIC SYNDROME//WAIST CIRCUMFERENCE//ABDOMINAL OBESITY |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GLUCOSE EFFECTIVENESS | Author keyword | 28 | 56% | 2% | 35 |
2 | INTRAVENOUS GLUCOSE TOLERANCE TEST | Author keyword | 18 | 36% | 2% | 39 |
3 | MINIMAL MODEL | Author keyword | 14 | 24% | 3% | 52 |
4 | BETA CELL FUNCTION | Author keyword | 10 | 14% | 4% | 67 |
5 | METAB MODELLING GRP | Address | 8 | 75% | 0% | 6 |
6 | DISPOSITION INDEX | Author keyword | 8 | 31% | 1% | 21 |
7 | SYST SCI BIOMED ENGN | Address | 7 | 36% | 1% | 16 |
8 | FAMILY HISTORY OF DIABETES | Author keyword | 6 | 41% | 1% | 12 |
9 | INSULINOGENIC INDEX | Author keyword | 6 | 34% | 1% | 15 |
10 | QUICKI | Author keyword | 6 | 29% | 1% | 16 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GLUCOSE EFFECTIVENESS | 28 | 56% | 2% | 35 | Search GLUCOSE+EFFECTIVENESS | Search GLUCOSE+EFFECTIVENESS |
2 | INTRAVENOUS GLUCOSE TOLERANCE TEST | 18 | 36% | 2% | 39 | Search INTRAVENOUS+GLUCOSE+TOLERANCE+TEST | Search INTRAVENOUS+GLUCOSE+TOLERANCE+TEST |
3 | MINIMAL MODEL | 14 | 24% | 3% | 52 | Search MINIMAL+MODEL | Search MINIMAL+MODEL |
4 | BETA CELL FUNCTION | 10 | 14% | 4% | 67 | Search BETA+CELL+FUNCTION | Search BETA+CELL+FUNCTION |
5 | DISPOSITION INDEX | 8 | 31% | 1% | 21 | Search DISPOSITION+INDEX | Search DISPOSITION+INDEX |
6 | FAMILY HISTORY OF DIABETES | 6 | 41% | 1% | 12 | Search FAMILY+HISTORY+OF+DIABETES | Search FAMILY+HISTORY+OF+DIABETES |
7 | INSULINOGENIC INDEX | 6 | 34% | 1% | 15 | Search INSULINOGENIC+INDEX | Search INSULINOGENIC+INDEX |
8 | QUICKI | 6 | 29% | 1% | 16 | Search QUICKI | Search QUICKI |
9 | FSIVGTT | 4 | 67% | 0% | 4 | Search FSIVGTT | Search FSIVGTT |
10 | GLUCOSE CLAMP | 4 | 14% | 1% | 23 | Search GLUCOSE+CLAMP | Search GLUCOSE+CLAMP |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MINIMAL MODEL | 45 | 24% | 9% | 162 |
2 | INTRAVENOUS GLUCOSE | 44 | 24% | 8% | 157 |
3 | LABELED IVGTT | 36 | 79% | 1% | 23 |
4 | TOLERANCE TEST | 26 | 20% | 6% | 115 |
5 | CHECK INDEX | 23 | 57% | 1% | 27 |
6 | MINIMAL MODEL ANALYSIS | 22 | 39% | 2% | 45 |
7 | HOMEOSTASIS MODEL ASSESSMENT | 21 | 11% | 10% | 179 |
8 | QUICKI | 19 | 70% | 1% | 16 |
9 | CLAMP | 19 | 14% | 7% | 126 |
10 | PIMA INDIANS | 18 | 10% | 9% | 173 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Use and abuse of HOMA modeling | 2004 | 1543 | 26 | 65% |
Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage | 2008 | 406 | 86 | 58% |
The assessment of insulin resistance in man | 2002 | 320 | 22 | 77% |
Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose | 2006 | 255 | 81 | 58% |
beta-Cell function in type 2 diabetes | 2014 | 6 | 80 | 46% |
Selection of the appropriate method for the assessment of insulin resistance | 2011 | 32 | 58 | 62% |
How can we measure insulin sensitivity/resistance? | 2011 | 24 | 70 | 74% |
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes | 2003 | 810 | 142 | 19% |
How to measure insulin sensitivity | 1998 | 284 | 43 | 65% |
The disposition index: adjustment for peripheral vs. hepatic insulin sensitivity? | 2010 | 16 | 20 | 80% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | METAB MODELLING GRP | 8 | 75% | 0.3% | 6 |
2 | SYST SCI BIOMED ENGN | 7 | 36% | 0.9% | 16 |
3 | METAB DIS DIABET UNIT | 5 | 54% | 0.4% | 7 |
4 | HLTH SUPPORT PROMOT SECT | 4 | 67% | 0.2% | 4 |
5 | GERIATR EDUC CLIN 3801 MIRANDA AVE | 4 | 75% | 0.2% | 3 |
6 | KARL LANDSTEINER METAB DIS NEPHROL | 3 | 57% | 0.2% | 4 |
7 | BIOCHEM EXERCISE NUTR | 3 | 27% | 0.5% | 9 |
8 | AMAGASAKI CITY OFF | 2 | 67% | 0.1% | 2 |
9 | INTERNAL MEDENDOCRINOL METAB SERV | 2 | 67% | 0.1% | 2 |
10 | MED 7873 | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000234501 | PROINSULIN//INTACT PROINSULIN//SPLIT PROINSULIN |
2 | 0.0000217390 | TG HDL C RATIO//TRIGLYCERIDE TO HDL CHOLESTEROL RATIO//DEOB |
3 | 0.0000154891 | ANTHROPOMETRIC CHANGES//AGING DIABET//CARDIOLEMORY OUTCOMES |
4 | 0.0000148096 | IMPAIRED FASTING GLUCOSE//DIABETES PREVENTION//IMPAIRED GLUCOSE TOLERANCE |
5 | 0.0000133620 | PEDIAT ENDOCRINOL METAB DIABET MELLITUS//WEIGHT MANAGEMENT WELLNESS//CHILDRENS GEN CLIN |
6 | 0.0000118725 | GLIMEPIRIDE//JTT 608//SECONDARY FAILURE |
7 | 0.0000115742 | GLUCONEOGENESIS//GLYCOGENOLYSIS//ENDOGENOUS GLUCOSE PRODUCTION |
8 | 0.0000094530 | JAPANESE BRAZILIANS//JAPANESE MIGRANTS//PREVALENCE OF DIABETES |
9 | 0.0000091947 | CALPAIN 10//MED CELLULAR MOL PHYSIOL BIOSTAT//MOL GENET COMPLEX MONOGEN DISORDERS |
10 | 0.0000087504 | METABOLICALLY HEALTHY OBESE//METABOLICALLY HEALTHY OBESITY//METABOLICALLY HEALTHY BUT OBESE |